Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: J Am Acad Dermatol. 2019 Dec 24;82(5):1150–1157. doi: 10.1016/j.jaad.2019.12.044

Table 1: Characteristics of Population in Each of the Trial Data.

Table reports N (% in parentheses) with median (25th and 75th percentile) and mean ± SD for age, BMI, nodules, abscesses, draining tunnel counts, and baseline IHS4. P values calculated using chi-squared or Fisher’s exact test for categorical variables, Mann-Whitney U test for non-normally distributed continuous data and Welch’s t-test for normally distributed continuous data.

Characteristic PIONEER 1 PIONEER 2
Adalimumab Placebo P value Adalimumab Placebo P value
N= 144 145 149 140
Female 85 (59.0%) 100 (69.0%) 0.10 97 (65.1%) 98 (70.0%) 0.45
Male 59 (41.0%) 45 (31.0%) 52 (34.9%) 42 (30.0%)
White 111 (77.1%) 113 (77.9%) 0.35 130 (87.2%) 110 (78.6%) 0.07
Black 30 (20.8%) 25 (17.2%) 8 (5.4%) 18 (12.9%)
Other 3 (2.1%) 7 (4.8%) 11 (7.4%) 12 (8.6%)
Median Age 35.0 (28.0, 45.0) 37.0 (30.0, 47.0) 0.14 35.0 (27.0, 42.0) 35.0 (26.0, 43.3) 0.49
Mean Age 36.5 ± 11.0 38.4 ± 11.4 34.8 ± 10.1 36.4 ± 12.2
Median BMI 32.1 (27.1, 38.0) 33.9 (28.5, 39.4) 0.07 30.3 (26.3, 36.0) 31.3 (26.8, 36.0) 0.22
Mean BMI 32.9 ± 7.7 34.6 ± 8.1 30.9 ± 6.4 31.8 ± 6.8
Hurley 2 80 (55.6%) 79 (54.5%) 0.95 76 (51.0%) 79 (56.4%) 0.42
Hurley 3 64 (44.4%) 66 (45.5%) 73 (49.0%) 61 (43.6%)
Nicotine Use 77 (53.5%) 88 (60.7%) 0.26 96 (64.4%) 99 (70.7%) 0.31
Family History 37 (25.7%) 28 (19.3%) 0.25 36 (24.2%) 39 (27.9%) 0.56
Presence of Draining Tunnels 108 (75.0%) 108 (74.5%) 1.0 99 (66.4%) 87 (62.1%) 0.52
Antibiotics - - 27 (18.1%) 28 (20.0%) 0.80
Median Nodules 8 (4.75, 14) 7 (4, 15) 0.88 6 (4,11) 6 (4, 10.25) 0.98
Mean Nodules 11.4 ± 11.1 11.6 ± 14.2 8.2 ± 6.0 8.8 ± 8.0
Median Abscesses 1.5 (0, 4) 2 (0, 3) 0.77 1 (0, 3) 1 (0, 3) 0.88
Mean Abscesses 2.7 ± 3.3 2.6 ± 3.6 2.0 ± 2.5 2.3 (3.2)
Median Draining Tunnels 2.5 (0.75, 7) 2 (0, 5) 0.38 2 (0, 4) 1 (0, 4) 0.60
Mean Draining Tunnels 4.5 ± 5.1 3.7 ± 4.3 3.0 ± 4.0 3.5 ± 5.8
Median Baseline IHS4 26.5 (15, 45.25) 25.0 (12, 40) 0.28 19 (10, 34) 18 (8.75, 32.25) 0.91
Mean Baseline IHS4 34.7 ± 26.8 31.6 ± 27.9 24.2 ± 20.0 27.3 ± 29.3